Lipid-mediated intracellular delivery of recombinant bioPROTACs for the rapid degradation of undruggable proteins

Abstract Recently, targeted degradation has emerged as a powerful therapeutic modality. Relying on “event-driven” pharmacology, proteolysis targeting chimeras (PROTACs) can degrade targets and are superior to conventional inhibitors against undruggable proteins. Unfortunately, PROTAC discovery is li...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Alexander Chan, Rebecca M. Haley, Mohd Altaf Najar, David Gonzalez-Martinez, Lukasz J. Bugaj, George M. Burslem, Michael J. Mitchell, Andrew Tsourkas
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Nature Portfolio 2024-07-01
סדרה:	Nature Communications
גישה מקוונת:	https://doi.org/10.1038/s41467-024-50235-x
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!